| Pharmaceutical active ingredients: |
| ClemastineDexamethasone |
| Available forms, composition and doses of Dexa Tavegil: |
| N / A |
| Dexa Tavegil medical category: |
| Human:Ethanolamine derivatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R06AA54 - Clemastine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dexa Fenicol | Chloramphenicol; Dexamethasone | Allergan |
| Dexa in der Ophtiole | Dexamethasone Sodium Phosphate | Dr. Gerhard Mann |
| Dexa Loscon | Benzoxonium Chloride; Dexamethasone Isonicotinate; Tioxolone | Galderma; Boehringer Ingelheim |
| Dexa Loscon Mono | Dexamethasone Isonicotinate | Galderma |
| Dexa Mamallet | Dexamethasone | Unidentified Pharmaceutical Company |
| Dexa Teosona | Dexamethasone; Theophylline | Phoenix Laboratorios |
| Dexa Vasoc | Dexamethasone; Naphazoline Hydrochloride; Zinc Sulfate | Novartis |
| Dexa-Allvoran | Dexamethasone Sodium Phosphate | TAD Pharma |
| Dexabene | Dexamethasone Sodium Phosphate | Ratiopharm; Merckle |
| Dexa-Biofenicol-N | Chloramphenicol; Dexamethasone; Tetracaine Hydrochloride | Dorsch |